Incidence, Predictors, and Outcomes of Endocarditis After Transcatheter Aortic Valve Replacement in the United States.

ABSTRACT:

Objectives

This study sought to evaluate the incidence and outcomes of endocarditis after transcatheter aortic valve replacement (TAVR).

Background

Data about endocarditis after TAVR are limited.

Methods

The study investigated Medicare patients who underwent TAVR from 2012 to 2017 and identified patients admitted with endocarditis during follow-up using a validated algorithm. The main study outcome was all-cause mortality.

Results

Of 134,717 patients who underwent TAVR, 1868 patients developed endocarditis during follow-up (incidence 0.87%/year), with majority of infections (65.0%) occurring within 1 year. Incidence of endocarditis declined in recent years. The most common organisms were Staphylococcus (22.0%), Streptococcus (20.0%), and Enterococcus (15.5%). I

SUBMITTER: Mentias A 

PROVIDER: S-EPMC7490767 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature